Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousBone Marrow TransplantationGraft vs Host DiseaseGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34MelphalanBlood Component RemovalCombined Modality TherapyStem CellsHematologic NeoplasmsHematopoietic Stem CellsMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeBusulfanLymphoma, Non-HodgkinStem Cell TransplantationGraft SurvivalMyeloablative AgonistsThiotepaEtoposideAntineoplastic Agents, AlkylatingRemission InductionCytophagocytosisRecurrenceIfosfamideSalvage TherapyImmunosuppressive AgentsCarmustineHematopoiesisCord Blood Stem Cell TransplantationVincristineHodgkin DiseaseCytarabineNeoplasmsAmyloidosisTissue DonorsRetrospective StudiesDisease-Free SurvivalBlood Cell CountSurvival RateTime FactorsBone Marrow PurgingBlood CellsDoxorubicinSurvival AnalysisWhole-Body IrradiationLymphoma, T-CellCarboplatinCytomegalovirus InfectionsPlatelet CountDexamethasoneRecombinant ProteinsHistocompatibilityInfectionEmbryonic Stem CellsHistocompatibility TestingPrednisoneTransplantation ChimeraAdult Stem CellsFollow-Up StudiesAntineoplastic AgentsProspective StudiesBlood Transfusion, AutologousLeukemia, Myeloid, AcuteCell SeparationLeukemiaLymphomaLeukocytes, MononuclearBlood DonorsFatal OutcomeFlow CytometryPluripotent Stem CellsFeasibility StudiesImmunophenotypingVidarabineOpportunistic InfectionsTransplantationT-LymphocytesImmunomagnetic SeparationCell DifferentiationCells, CulturedImmunocompromised HostHematologic DiseasesStem Cell FactorStem Cell NicheAnemia, AplasticFetal BloodKidney TransplantationFeverBone Marrow CellsBreast NeoplasmsPOEMS Syndrome